Cervical cancer is the second most common gynecological malignancy in developing countries and remains a major cause of cancer-related mortality among women worldwide. This retrospective descriptive study, conducted on 38 cases at the General Surgery Department of the Avicenne Military Hospital in Marrakech from 2018 to 2022, revealed a predominance of squamous cell carcinoma in women aged 50 to 60 years. Vaginal bleeding was the main presenting symptom. Concomitant chemoradiotherapy based on weekly cisplatin followed by uterovaginal brachytherapy was the most frequently used treatment. Strengthening and expanding cervical cancer screening programs remain crucial to improve early detection and patient outcomes.